We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+19.43%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.75B
AUM Growth
+$77.9M
Cap. Flow
-$78.7M
Cap. Flow %
-4.49%
Top 10 Hldgs %
55.92%
Holding
150
New
22
Increased
25
Reduced
39
Closed
26

Top Buys

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$15.1M
2
TRML
Tourmaline Bio
TRML
+$10.2M
3
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$6.91M
4
EHTH icon
eHealth
EHTH
+$6.1M
5
CONN
Conn's Inc.
CONN
+$6.03M

Top Sells

Rank Stock Value
1
ESTA icon
Establishment Labs
ESTA
+$20.3M
2
SLNO
Soleno Therapeutics
SLNO
+$20.2M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$19.5M
4
LXFR icon
Luxfer Holdings
LXFR
+$10.1M
5
CYTK icon
Cytokinetics
CYTK
+$9.19M

Sector Composition

Rank Sector Weight
1 Healthcare 36.87%
2 Consumer Discretionary 8.07%
3 Financials 4.11%
4 Communication Services 3.43%
5 Technology 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPTN
76
DELISTED
OptiNose
OPTN
$3.61M 0.21%
164,953
-44,842
-21% -$995K
AYTU icon
77
AYTU BioPharma
AYTU
$25.9M
$3.3M 0.19%
1,086,812
– –
MIST icon
78
Milestone Pharmaceuticals
MIST
$157M
$3.13M 0.18%
+1,750,000
New +$2.84M
STKS icon
79
The ONE Group
STKS
$56.5M
$3.05M 0.17%
+547,710
New +$2.4M
MAX icon
80
MediaAlpha
MAX
$801M
$3.04M 0.17%
149,371
-31,497
-17% -$503K
ACHV icon
81
Achieve Life Sciences
ACHV
$706M
$2.97M 0.17%
+654,000
New +$2.9M
GAIA icon
82
Gaia
GAIA
$32.4M
$2.82M 0.16%
915,029
– –
NVNO
83
enVVeno Medical
NVNO
$7.31M
$2.7M 0.15%
14,164
-6,017
-30% -$1.08M
JBIO
84
Jade Biosciences
JBIO
$1.36B
$2.7M 0.15%
2,605
– –
NKTR icon
85
Nektar Therapeutics
NKTR
$2.53B
$2.31M 0.13%
+165,064
New +$1.73M
ASPS icon
86
Altisource Portfolio Solutions
ASPS
$64.6M
$2.12M 0.12%
136,376
+3,362
+3% +$74.5K
TLPH icon
87
Talphera
TLPH
$76.8M
$2.05M 0.12%
1,992,519
+755,000
+61% +$805K
RNTX
88
Rein Therapeutics
RNTX
$70.1M
$1.69M 0.1%
+255,000
New +$1.22M
IMTXW
89
DELISTED
Immatics N.V. Warrants
IMTXW
$1.51M 0.09%
558,977
– –
SRL icon
90
Scully Royalty
SRL
$90.1M
$1.47M 0.08%
239,197
-3,524
-1% -$26.4K
ANEB
91
DELISTED
Anebulo Pharmaceuticals
ANEB
$1.47M 0.08%
511,073
– –
NMTC icon
92
NeuroOne Medical Technologies
NMTC
$14.2M
$1.44M 0.08%
199,819
-2,530
-1% -$19.1K
PWP icon
93
Perella Weinberg Partners
PWP
$1.31B
$1.41M 0.08%
99,778
-55,931
-36% -$703K
APRE icon
94
Aprea Therapeutics
APRE
$8.48M
$1.38M 0.08%
+205,760
New +$1.28M
TIL icon
95
Instil Bio
TIL
$50.9M
$1.37M 0.08%
127,292
– –
KPRX icon
96
Kiora Pharmaceuticals
KPRX
$11.5M
$1.34M 0.08%
+211,111
New +$1.18M
FOSL icon
97
Fossil Group
FOSL
$314M
$1.33M 0.08%
1,306,338
+901,060
+222% +$1.01M
RILY icon
98
BRC Group Holdings
RILY
$293M
$1.32M 0.08%
62,520
– –
QURE icon
99
CALL
uniQure
QURE
$3.11B
$1.26M 0.07%
243,000
+43,000
+22% +$247K
MTTR
100
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$1.24M 0.07%
+548,376
New +$1.2M
2 3
4
5 6

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return

Nantahala Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Nantahala Capital Management held 150 positions worth $1.75B, up 4.7% from $1.67B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nantahala Capital Management withdrew a net $78.7M in Q1 2024, closing 26 positions and reducing 39 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Nantahala Capital Management opened a new position in Eagle Pharmaceuticals, Inc. worth $6.6M.

  • Nantahala Capital Management's largest Q1 2024 buy was Eagle Pharmaceuticals, Inc.: 1,258,762 shares worth $6.6M.
  • Nantahala Capital Management added most to Peloton Interactive in Q1 2024, an estimated $15.1M increase.
  • Nantahala Capital Management's biggest Q1 2024 reduction was Establishment Labs, cutting an estimated $20.3M.
  • Nantahala Capital Management fully exited iShares Russell 2000 ETF in Q1 2024, selling an estimated $19.5M.
  • Nantahala Capital Management's ten largest holdings make up 56% of its $1.75B portfolio in Q1 2024.
  • Nantahala Capital Management opened 22 new positions and closed 26 in Q1 2024.
  • Nantahala Capital Management's portfolio value rose 4.7% quarter-over-quarter to $1.75B.

Based on Nantahala Capital Management's 13F filing for Q1 2024, filed 15 May 2024.